2020 Fiscal Year Annual Research Report
Encapsulation of alpha-synuclein oligomers into a protein cage to elucidate the dynamic behavior.
Project/Area Number |
19K15695
|
Research Institution | Tokyo Institute of Technology |
Principal Investigator |
Maity Basudev 東京工業大学, 生命理工学院, 特任助教 (60815421)
|
Project Period (FY) |
2019-04-01 – 2021-03-31
|
Keywords | Ferritin cage / Alpha-synuclein oligomer / High-speed AFM |
Outline of Annual Research Achievements |
We have successfully fused the amyloid peptides (Amyloid beta and Alpha-synuclein) at the C-terminal of the ferritin cage and thus, isolated a precise number of such peptides into a confined protein environment. For amyloid beta which is a 42-residue peptide, the ferritin maintained the 24-mer spherical cage. The encapsulated peptide formed beta-sheet structure inside the cage which is confirmed by the ThT assay and Fr-IR analysis. We studied the movement fo the ferritin cage and the disassembly of the cage which expose the encapsulated amyloid beta oligomer surrounded by the ferritin subunits. For alpha-synuclein which is a 140 amino acid residue, ferritin cage did not formed due the length of the peptide. Therefore, we divided the peptide into three sections after analyzing the structure. The residue 61-95 which is mostly responsible for the beta-sheet formation was chosen and fused with the C-terminal of the ferritin cage. Ferritin cage was formed with such fragment which was characterized by MALDI however, the X-ray crystal structure did not show the position of the encapsulated peptides indicating that the peptides are dynamic in the cage. Using high-speed AFM, we observed the oligomeric state of alpha-synuclein by disassembling ferritin cage. Unlike amyloid beta peptide, the alpha-synuclein oligomer dissociates with time. Overall, our studies demonstrated the precise encapsulation of amylogenic peptides into a restricted space which usually difficult to study in solution.
|